Clinical Trials · NCT01557166
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 359
- Start date
- Jun 2012
- Locations
- 42 sites, United States, Canada
- Primary endpoint
- Change From Baseline in Apnoea-hypopnoea Index (AHI)